https://www.businesswire.com/news/home/20190114005721/en/

LONDON--(BUSINESS WIRE)--Jan 15, 2019--EMMAC Life Sciences PLC (“EMMAC” or the “Company”), the European independent medical cannabis company, is pleased to announce the appointment of two internationally acclaimed scientific leaders to its Board and Leadership team. Dr Barbara Pacchetti has been appointed Chief Scientific Officer joining the Board and will spearhead EMMAC’s commitment to developing the highest quality cannabis product research and innovation globally. Dr Mikael Sodergren, a world-respected academic clinician, will join EMMAC’s leadership team with the pivotal role of overseeing research projects designed to shape the future of medical cannabis therapeutics.

Prior to joining EMMAC, Dr Pacchetti held the position of Scientific Affairs Manager at Linnea, a manufacturer of Botanical extracts and pharmaceutical ingredients of natural origin for use in the pharmaceutical, nutraceutical and cosmetic industries.